Oncopep, Inc logo
VerifiedBiotechnology Research

Oncopep, Inc

Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell focused technologies are designed to be used on their own or in combination with other immunotherapeutics.

7-day free trial · no credit card

HeadquartersBoston, United StatesEmployees4(11 to 50)Annual revenue<$1MWebsiteoncopep.comLinkedIn profileLinkedIn

Verified contacts

4

available on Kipplo

LinkedIn employees

4

11 to 50 range

Open roles

no listings

Distinct roles

4

indexed titles

Tech stack

5

tools in use

Monthly traffic

26

organic / mo

Sign up free to see all 4 verified contacts at Oncopep, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

4 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 1 of 4 verified contacts

Top roles at Oncopep, Inc

4 distinct titles indexed · top 4 shown.

  • 1chief financial officer
  • 1chief strategy officer (cso)
  • 1human resources coordinator
  • 1senior staff accountant

Sign up to unlock all 4 contacts at Oncopep, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 4 verified contacts at Oncopep, Inc

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Oncopep, Inc | Kipplo Discover